Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 29,621 | 28,028 | 27,687 | 29,014 | 35,042 |
| Operating Income | -29,621 | -28,028 | -27,687 | -29,014 | -35,042 |
| Other Income | 880 | 1,169 | 1,350 | 1,729 | 2,072 |
| Pre-tax Income | -28,741 | -26,859 | -26,337 | -27,285 | -32,970 |
| Net Income Continuous | -28,741 | -26,859 | -26,337 | -27,285 | -32,970 |
| Net Income | $-28,741 | $-26,859 | $-26,337 | $-27,285 | $-32,970 |
| EPS Basic Total Ops | -0.75 | -0.70 | -0.69 | -0.71 | -0.87 |
| EPS Basic Continuous Ops | -0.75 | -0.70 | -0.69 | -0.72 | -0.87 |
| EPS Diluted Total Ops | -0.75 | -0.70 | -0.69 | -0.71 | -0.87 |
| EPS Diluted Continuous Ops | -0.75 | -0.70 | -0.69 | -0.72 | -0.87 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.70 | -0.69 | -0.71 | -0.87 |
| EBITDA(a) | $-29,435 | $-27,951 | $-27,711 | $-29,052 | $-35,192 |